Van Cutsem E - Search Results

1

Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

Van Cutsem E, Vervenne WL, Bennouna J, Humblet Y, Gill S, Van Laethem JL, Verslype C, Scheithauer W, Shang A, Cosaert J, Moore MJ. Van Cutsem E, et al. Among authors: van laethem jl. J Clin Oncol. 2009 May 1;27(13):2231-7. doi: 10.1200/JCO.2008.20.0238. Epub 2009 Mar 23. J Clin Oncol. 2009. PMID: 19307500 Clinical Trial.

2

Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study.

Van Cutsem E, Filez L, Dewyspelaere J, Penninckx F, Janssens J. Van Cutsem E, et al. Anticancer Res. 1995 May-Jun;15(3):1079-80. Anticancer Res. 1995. PMID: 7645929 Clinical Trial.

3

Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.

Cocconi G, Cunningham D, Van Cutsem E, Francois E, Gustavsson B, van Hazel G, Kerr D, Possinger K, Hietschold SM. Cocconi G, et al. Among authors: van cutsem e, van hazel g. J Clin Oncol. 1998 Sep;16(9):2943-52. doi: 10.1200/JCO.1998.16.9.2943. J Clin Oncol. 1998. PMID: 9738562 Clinical Trial.

4

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer.

Van Cutsem E, Pozzo C, Starkhammar H, Dirix L, Terzoli E, Cognetti F, Humblet Y, Garufi C, Filez L, Gruia G, Cote C, Barone C. Van Cutsem E, et al. Ann Oncol. 1998 Nov;9(11):1199-204. doi: 10.1023/a:1008478405634. Ann Oncol. 1998. PMID: 9862050 Free article. Clinical Trial.

5

Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer.

Flamen P, Stroobants S, Van Cutsem E, Dupont P, Bormans G, De Vadder N, Penninckx F, Van Hoe L, Mortelmans L. Flamen P, et al. Among authors: van cutsem e, van hoe l. J Clin Oncol. 1999 Mar;17(3):894-901. doi: 10.1200/JCO.1999.17.3.894. J Clin Oncol. 1999. PMID: 10071281

6

Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group.

Van Cutsem E, Blijham GH. Van Cutsem E, et al. Semin Oncol. 1999 Feb;26(1 Suppl 5):13-20. Semin Oncol. 1999. PMID: 10213010 Clinical Trial.

7

The medical treatment of colorectal cancer: actual status and new developments.

Van Cutsem E, Peeters M, Verslype C, Filez L, Haustermans K, Janssens J. Van Cutsem E, et al. Hepatogastroenterology. 1999 Mar-Apr;46(26):709-16. Hepatogastroenterology. 1999. PMID: 10370599 Review.

8

Developments in fluoropyrimidine therapy for gastrointestinal cancer.

Van Cutsem E, Peeters M. Van Cutsem E, et al. Curr Opin Oncol. 1999 Jul;11(4):312-7. doi: 10.1097/00001622-199907000-00012. Curr Opin Oncol. 1999. PMID: 10416885 Review.

9

Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectives.

Van Cutsem E. Van Cutsem E. Eur J Cancer. 1999 Mar;35 Suppl 1:S1-2. doi: 10.1016/s0959-8049(99)00040-4. Eur J Cancer. 1999. PMID: 10645206 Review.

10

Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study.

Van Cutsem E, Findlay M, Osterwalder B, Kocha W, Dalley D, Pazdur R, Cassidy J, Dirix L, Twelves C, Allman D, Seitz JF, Schölmerich J, Burger HU, Verweij J. Van Cutsem E, et al. J Clin Oncol. 2000 Mar;18(6):1337-45. doi: 10.1200/JCO.2000.18.6.1337. J Clin Oncol. 2000. PMID: 10715306 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

764 results

Search Page

Filters